Trends Related to Aging and Co-Occurring Disorders in HIV-Infected Drug Users

REFERENCES

• Adler, W. H., Baskar, P. V., Chrest, F. J., Dorsey-Cooper, B., Winchurch, R. A., & Nagel, J. E. (1997). HIV infection and aging: Mechanisms to explain the accelerated rate of progression in the older patient. Mechanisms of Ageing and Development, 96(1–3), 137–155.
   PubMed Web of Science ®Google Scholar
• Alexander, J., & Clearfield, M. (2006). Cardiovascular disease after menopause: A growing epidemic. Minerva Ginecologica, 58, 35–40.
   PubMedGoogle Scholar
• Alexopoulos, G. S. (2005). Depression in the elderly. Lancet, 365, 1961–1970.
   PubMed Web of Science ®Google Scholar
• Alexopoulos, G. S., Buckwalter, K., Olin, J., Martinez, R., Wainscott, C., & Krishnan, K. (2002). Comorbidity of late-life depression: An opportunity for research in mechanisms and treatment. Biological Psychiatry, 52, 543–558.
   PubMed Web of Science ®Google Scholar
• Alter, M. J. (2006). Epidemiology of viral hepatitis and HIV co-infection. Journal of Hepatology, 44(Suppl. 1), S6–S9.
   PubMed Web of Science ®Google Scholar
• Anthony, I. C., Arango, J. C., Stephens, B., Simmonds, P., & Bell, J. E. (2008). The effects of illicit drugs on the HIV infected brain. Frontiers in Bioscience, 13, 1294–1307.
   PubMed Web of Science ®Google Scholar
• Appel, G. (2007). Viral infections and the kidney: HIV, hepatitis B, and hepatitis C. Cleveland Clinic Journal of Medicine, 74, 353–360.
   PubMed Web of Science ®Google Scholar
• Araujo, A. B., O'Donnell, A. B., Brambilla, D. J., Simpson, W. B., Longcope, C., Matsumoto, A. M., (2004). Prevalence and incidence of androgen deficiency in middle-aged and older men: Estimates from the Massachusetts Male Aging Study. Journal of Clinical Endocrinology and Metabolism, 89(12), 5920–5926.
   PubMed Web of Science ®Google Scholar
• Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17(5), 377–381.
   PubMed Web of Science ®Google Scholar
• Arnsten, J. H., Freeman, R., Howard, A. A., Floris-Moore, M., Lo, Y., & Klein, R. S. (2007). Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS, 21, 617–623.
   PubMed Web of Science ®Google Scholar
• Arnsten, J. H., Freeman, R., Howard, A. A., Floris-Moore, M., Santoro, N., & Schoenbaum, E. E. (2006). HIV infection and bone mineral density in middle-aged women. Clinical Infectuous Diseases, 42(7), 1014–1020.
   PubMed Web of Science ®Google Scholar
• Bangsberg, D. R. (2008). Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. Journal of Infectious Diseases, 197(Suppl. 3), S272–S278.
   PubMed Web of Science ®Google Scholar
• Bartlett, J. A., DeMasi, R., Quinn, J., Moxham, C., & Rousseau, F. (2001). Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults. AIDS, 15(11), 1369–1377.
   PubMed Web of Science ®Google Scholar
• Becker, J. T., Lopez, O. L., Dew, M. A., & Aizenstein, H. J. (2004). Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS, 18(Suppl. 1), S11–S18.
   PubMed Web of Science ®Google Scholar
• Behrens, G., Dejam, A., Schmidt, H., Balks, H. J., Brabant, G., Korner, T., (1999). Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS, 13(10), F63–F70.
   PubMed Web of Science ®Google Scholar
• Bell, J. E., Arango, J. C., & Anthony, I. C. (2006). Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs. Journal of Neuroimmune Pharmacology, 1(2), 182–191.
   PubMed Web of Science ®Google Scholar
• Bertolote, J. M., Fleischmann, A., De Leo, D., & Wasserman, D. (2004). Psychiatric diagnoses and suicide: Revisiting the evidence. Crisis, 25(4), 147–155.
   PubMedGoogle Scholar
• Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., et al. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58, 721–728.
   PubMed Web of Science ®Google Scholar
• Bozzette, S. A., Ake, C. F., Tam, H. K., Chang, S. W., & Louis, T. A. (2003). Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. New England Journal of Medicine, 348(8), 702–710.
   PubMed Web of Science ®Google Scholar
• Brown, T. T., & Qaqish, R. B. (2006). Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review. AIDS, 20(17), 2165–2174.
   PubMed Web of Science ®Google Scholar
• Buckner, R. L. (2004). Memory and executive function in aging and AD: Multiple factors that cause decline and reserve factors that compensate. Neuron, 44, 195–208.
   PubMed Web of Science ®Google Scholar
• Carr, A., Samaras, K., Thorisdottir, A., Kaufmann, G. R., Chisholm, D. J., & Cooper, D. A. (1999). Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidemia, and diabetes mellitus: A cohort study. Lancet, 353, 2093–2099.
   PubMed Web of Science ®Google Scholar
• Casey, D. A. (1994). Depression in the elderly. Southern Medical Journal, 87(5), 559–563.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (1981). Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men—New York City and California. Morbidity and Mortality Weekly Report, 30(25), 305–308.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. (1992). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report, 41(RR-17), 1–19.
   Google Scholar
• Centers for Disease Control and Prevention. (1999). AIDS cases diagnosed in 1977 and 1998 by sex, race/ethnicity, age at diagnosis and risk exposure. HIV Surveillance Supplemental Report, 5(3), 1–12.
   Google Scholar
• Centers for Disease Control and Prevention. (2006). Cases of HIV infection and AIDS in the United States, by race/ethnicity, 2000–2004. HIV/AIDS Surveillance Supplemental Report, 12(1), 1–36.
   Google Scholar
• Centers for Disease Control and Prevention. Diagnosis rates of HIV/AIDS among persons aged 13 and older, by area of residence, 2006-33 states and 5 U.S. dependent areas with confidential name-based HIV infection reporting. HIV/AIDS Surveillance Report (2006), 18, 1–55.
   Google Scholar
• Chapman, D. P., & Perry, G. S. (2008). Depression as a major component of public health for older adults. Preventing Chronic Disease, 5(1). Retrieved July 28, 2008, from http://www.cdc.gov/pcd/issues/2008/jan/07_0150.htm
   PubMedGoogle Scholar
• Cherubin, C. E., & Sapira, J. D. (1993). The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Annals of Internal Medicine, 119(10), 1017–1028.
   PubMed Web of Science ®Google Scholar
• Cheruvu, S., Marks, K., & Talal, A. H. (2007). Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection. Clinics in Liver Disease, 11(4), 917–943.
   PubMedGoogle Scholar
• Chesney, M. A. (2000). Factors affecting adherence to antiretroviral therapy. Clinical Infectious Diseases, 30(Suppl. 2), S171–S176.
   PubMed Web of Science ®Google Scholar
• Chiesi, A., Seeber, A. C., Dally, L. G., Floridia, M., Rezza, G., & Vella, S. (1996). AIDS dementia complex in the Italian National AIDS Registry: Temporal trends (1987–1993) and differential incidence according to mode of transmission of HIV-1 infection. Journal of the Neurological Sciences, 144, 107–113.
   PubMed Web of Science ®Google Scholar
• Cicero, T. J. (1980). Effects of exogenous and endogenous opiates on the hypothalamic–pituitary–gonadal axis in the male. Federation Proceedings, 39, 2551–2554.
   PubMedGoogle Scholar
• Ciesla, J. A., & Roberts, J. E. (2001). Meta-analysis of the relationship between HIV infection and risk for depressive disorders. American Journal of Psychiatry, 158, 725–730.
   PubMed Web of Science ®Google Scholar
• Cooper, O. B., Brown, T. T., & Dobs, A. S. (2003). Opiate drug use: A potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease. Clinical Infectious Diseases, 37(Suppl. 2), S132–S136.
   PubMed Web of Science ®Google Scholar
• Cummings, S. R., & Melton, I. L. J. (2002). Epidemiology and outcomes of osteoporotic fractures. Lancet, 359, 1761–1767.
   PubMed Web of Science ®Google Scholar
• The Data Collection on Adverse Events of Anti-HIV Drugs Study Group. (2006). Liver-related deaths in persons infected with the human immunodeficiency virus. Archives of Internal Medicine, 166, 1632–1641.
   PubMedGoogle Scholar
• Davis, L., Uezato, A., Newell, J. M., & Frazier, E. (2008). Major depression and comorbid substance use disorders. Current Opinion in Psychiatry, 21(1), 14–18.
   PubMed Web of Science ®Google Scholar
• DeCarli, C. (2003). The role of cererbrovascular disease in dementia. Neurologist, 9(3), 123–136.
   PubMed Web of Science ®Google Scholar
• Dobs, A. S., Dempsey, M. A., Ladenson, P. W., & Polk, B. F. (1988). Endocrine disorders in men infected with human immunodeficiency virus. American Journal of Medicine, 84, 611–616.
   PubMed Web of Science ®Google Scholar
• Dobs, A. S., Few, W. L., Blackman, M. R., Harman, S. M., Hoover, D. R., & Graham, N. M. (1996). Serum hormones in men with human immunodeficiency virus associated wasting. Journal of Clinical Endocrinology and Metabolism, 81, 4108–4112.
   PubMed Web of Science ®Google Scholar
• Dube, M. P., Stein, J. H., Aberg, J. A., Fichtenbaum, C. J., Gerber, J. G., Tashima, K. T., (2003). Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: Recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clinical Infectious Diseases, 37(5), 613–627.
   PubMed Web of Science ®Google Scholar
• Friis-Moller, N., Reiss, P., Sabin, C. A., Weber, R., Monforte, A., El-Sadr, W., (2007). Class of antiretroviral drugs and the risk of myocardial infarction. New England Journal of Medicine, 356(17), 1723–1735.
   PubMed Web of Science ®Google Scholar
• Friis-Moller, N., Sabin, C. A., Weber, R., d'Arminio Monforte, A., El-Sadr, W. M., Reiss, P., (2003). Combination antiretroviral therapy and the risk of myocardial infarction. New England Journal of Medicine, 349(21), 1993–2003.
   PubMed Web of Science ®Google Scholar
• Frishman, W. H., Del Vecchio, A., Sanal, S., & Ismail, A. (2003). Cardiovascular manifestations of substance abuse. Part 1: Alcohol, amphetamines, heroin, cannabis, and caffeine. Heart Disease, 5(4), 253–271.
   PubMedGoogle Scholar
• Frishman, W. H., Del Vecchio, A., Sanal, S., & Ismail, A. (2003). Cardiovascular manifestations of substance abuse. Part 1. Cocaine. Heart Disease, 5, 187–201.
   PubMedGoogle Scholar
• Ganem, D. (1998). Human herpesvirus 8 and its role in the genesis of Kaposi's sarcoma. Current Clinical Topics in Infectious Diseases, 18, 237–251.
   PubMedGoogle Scholar
• Geiss, L. S., Herman, W. H., Goldschmid, M. G., DeStefano, F., Eberhardt, M., Ford, E. S., (1993). Surveillance for diabetes mellitus—United States, 1980–1989. Morbidity and Mortality Weekly Report Surveillance Summary, 42(2), 1–20.
   PubMedGoogle Scholar
• Gibbie, T., Mijch, A., Ellen, S., Hoy, J., Hutchison, C., Wright, E., (2006). Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up. HIV Medicine, 7(2), 112–121.
   PubMed Web of Science ®Google Scholar
• Gkrania-Klotsas, E., & Klotsas, A. (2007). HIV and HIV treatment: Effects on fats, glucose and lipids. British Medical Bulletin, 84, 49–68.
   PubMed Web of Science ®Google Scholar
• Gorard, D. A. (2006). Escalating polypharmacy. Quarterly Journal of Medicine, 99, 797–800.
   Google Scholar
• Gougeon, M. L., Penicaud, L., Fromenty, B., Leclercq, P., Viard, J. P., & Capeau, J. (2004). Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations. Antiviral Therapy, 9(2), 161–177.
   PubMed Web of Science ®Google Scholar
• Grabar, S., Kousignian, I., Sobel, A., Le Bras, P., Gasnault, J., Enel, P., (2004). Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV. AIDS, 18(15), 2029–2038.
   PubMed Web of Science ®Google Scholar
• Grimes, R. M., Otiniano, M. E., Rodriguez-Barradas, M. C., & Lai, D. (2002). Clinical experience with human immunodeficiency virus-infected older patients in the era of effective antiretroviral therapy. Clinical Infectious Diseases, 34, 1530–1533.
   PubMed Web of Science ®Google Scholar
• Grinspoon, S., Corcoran, C., Lee, K., Burrows, B., Hubbard, J., Katznelson, L., (1996). Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. Journal of Clinical Endocrinology and Metabolism, 81(11), 4051–4058.
   PubMed Web of Science ®Google Scholar
• Gupta, S. K., Eustace, J. A., Winston, J. A., Boydstun, I. I., Ahuja, T. S., Rodriguez, R. A., (2005). Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases, 40(11), 1559–1585.
   PubMed Web of Science ®Google Scholar
• Hadigan, C., Meigs, J. B., Corcoran, C., Rietschel, P., Piecuch, S., Basgoz, N., (2001). Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clinical Infectious Diseases, 32(1), 130–139.
   PubMed Web of Science ®Google Scholar
• Hartel, D. M., Schoenbaum, E. E., Lo, Y., & Klein, R. S. (2006). Gender differences in illicit substance use among middle-aged drug users with or at risk for HIV infection. Clinical Infectious Diseases, 43, 625–631.
   Web of Science ®Google Scholar
• Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., (2004). Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS, 18(Suppl. 1), S19–S25.
   PubMed Web of Science ®Google Scholar
• Howard, A. A., Floris-Moore, M., Arnsten, J. H., Santoro, N., Fleischer, N., Lo, Y., (2005). Disorders of glucose metabolism among HIV-infected women. Clinical Infectious Diseases, 40(10), 1492–1499.
   PubMed Web of Science ®Google Scholar
• Howard, A. A., Floris-Moore, M., Lo, Y., Arnsten, J. H., Fleischer, N., & Klein, R. S. (2006). Abnormal glucose metabolism among older men with or at risk of HIV infection. HIV Medicine, 7(6), 389–396.
   PubMed Web of Science ®Google Scholar
• Hu, S., Sheng, W. S., Lokensgard, J. R., & Peterson, P. K. (2005). Morphine potentirates HIV-1 gp120-induced neuronal apoptosis. Journal of Infectious Diseases, 191, 886–889.
   PubMed Web of Science ®Google Scholar
• Ickovics, J. R., Hamburger, M. E., Vlahov, D., Schoenbaum, E. E., Schuman, P., Boland, R. J., (2001). Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study. Journal of the American Medical Association, 285(11), 1466–1474.
   PubMed Web of Science ®Google Scholar
• Jaffe, H. W., Bregman, D. J., & Selik, R. M. (1983). Acquired immune deficiency syndrome in the United States: The first 1,000 cases. Journal of Infectious Diseases, 148(2), 339–345.
   PubMed Web of Science ®Google Scholar
• Jaffe, J. A., & Kimmel, P. L. (2006). Chronic nephropathies of cocaine and heroin abuse: A critical review. Clinical Journal of the American Society of Nephrology, 1, 655–667.
   PubMed Web of Science ®Google Scholar
• Justice, A. C., McGinnisa, K. A., & Atkinson, J. H. (2004). Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans aging cohort five-site study. AIDS, 18(Suppl. 1), S49–S69.
   PubMed Web of Science ®Google Scholar
• Kaarbo, M., Lkokk, T. I., & Saatcioglu, F. (2007). Androgen signaling and its interactions with other signaling pathways in prostate cancer. Bioessays, 29, 1227–1238.
   PubMed Web of Science ®Google Scholar
• Kanis, J. A., Gluer, C. C., for the Committee of Scientific Advisors International Osteoporosis Foundation. (2000). An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporosis International, 11, 192–202.
   PubMed Web of Science ®Google Scholar
• Klein, R. S., Lo, Y., Santoro, N., & Dobs, A. S. (2005). Androgen levels in older men who have or who are at risk of acquiring human immunodeficiency virus infection. Clinical Infectious Diseases, 41, 1794–1803.
   PubMed Web of Science ®Google Scholar
• Langford, D., Grigorian, A., Hurford, R., Adame, A., Crews, L., & Masliah, E. (2004). The role of mitochrondrial alterations in the combined toxic effects of human immunodeficiency viral Tat protein and methamphetamine on calbidin postitive-neurons. Journal of Neurovirology, 10(6), 327–337.
   PubMed Web of Science ®Google Scholar
• Law, M. R., & Hackshaw, A. K. (1997). A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: Recognition of a major effect. British Medical Journal, 315, 841–846.
   PubMed Web of Science ®Google Scholar
• Lee, G. A., Seneviratne, T., Noor, M. A., Lo, J. C., Schwarz, J. M., Aweeka, F. T., (2004). The metabolic effects of lopinavir/ritonavir in HIV-negative men. AIDS, 18(4), 641–649.
   PubMed Web of Science ®Google Scholar
• Leibson, C. L., Rocca, W. A., Hanson, V. A., Cha, R., Kokmen, E., O'Brien, P. C., (1997). The risk of dementia among persons with diabetes mellitus: A population-based cohort study. Annals of the New York Academy of Sciences, 826, 422–427.
   PubMedGoogle Scholar
• Liu, H., Paige, N. M., Goldzweig, C. L., Wong, E., Zhou, A., Suttorp, M. J., (2008). Screening for osteoporosis in men: A systematic review for an American College of Physicians guideline. Annals of Internal Medicine, 148(9), 685–701.
   PubMed Web of Science ®Google Scholar
• Macdonald, S., Anglin-Bodrug, K., Mann, R. E., Erickson, P., Hathaway, A., Chipman, M., (2003). Injury risk associated with cannabis and cocaine use. Drug and Alcoholol Dependence, 72(2), 99–115.
   PubMed Web of Science ®Google Scholar
• McArthur, J. C., Hoover, D. R., Bacellar, H., Miller, E. N., Cohen, B. A., Becker, J. T., (1993). Dementia in AIDS patients: Incidence and risk factors. Multicenter AIDS Cohort Study. Neurology, 43(11), 2245–2252.
   PubMed Web of Science ®Google Scholar
• McGinnis, J. M., & Foege, W. H. (1999). Mortality and morbidity attributable to use of addictive substances in the United States. Proceedings of the Association of American Physicians, 111(2), 109–118.
   PubMedGoogle Scholar
• McLean, A. J., & Le Couteur, D. G. (2004). Aging biology and geriatric clinical pharmacology. Pharmacological Reviews, 56, 163–184.
   PubMed Web of Science ®Google Scholar
• Michelson, D., Stratakis, C., Hill, L., Reynolds, J., Galliven, E., Chrousos, G., (1996). Bone mineral density in women with depression. New England Journal of Medicine, 335(16), 117611–117681.
   Web of Science ®Google Scholar
• Moore, R. D., & Chaisson, R. E. (1999). Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS, 13(14), 1933–1942.
   PubMed Web of Science ®Google Scholar
• Mulligan, K., Grunfeld, C., Tai, V. W., Algren, H., Pang, M., Chernoff, D. N., (2000). Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 23(1), 35–43.
   PubMed Web of Science ®Google Scholar
• Murata, H., Hruz, P. W., & Mueckler, M. (2000). The mechanism of insulin resistance caused by HIV protease inhibitor therapy. Journal of Biological Chemistry, 275, 20251–20254.
   PubMed Web of Science ®Google Scholar
• National Institute of Arthritis and Musculoskeletal and Skin Diseases. (2008). Osteoporosis. Retrieved July 9, 2008, from http://www.niams.nih .gov/Health_Info/Bone/Osteoporosis/default.asp
   Google Scholar
• New York City Department of Health and Mental Hygiene. (2008). New York City HIV/AIDS Annual Surveillance Statistics. Updated November 2008. Retrieved July 2, 2008, from http://www.nyc.gov/html/doh/html/ah/hivtables.shtml
   Google Scholar
• Niaura, R., Shadel, W. G., Morrow, K., Tashima, K., Flanigan, T., & Abrams, D. B. (2000). Human immunodeficiency virus infection, AIDS, and smoking cessation: The time is now. Clinical Infectious Diseases, 31, 808–812.
   PubMed Web of Science ®Google Scholar
• Nogueras, M., Navarro, G., & Anton, E. (2006). Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more. BMC Infectious Diseases, 6, 159.
   PubMed Web of Science ®Google Scholar
• Noor, M. A., Lo, J. C., Mulligan, K., Schwarz, J. M., Halvorsen, R. A., Schambelan, M., (2001). Metabolic effects of indinavir in healthy HIV-seronegative men. AIDS, 15(7), F11–F18.
   PubMed Web of Science ®Google Scholar
• Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybaerg-Hansen, A. (2007). Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. Journal of the American Medical Association, 298, 299–308.
   PubMed Web of Science ®Google Scholar
• North American Menopause Society. (2006). Management of osteoporosis in postmenopausal women: 2006 position statement of the North American Menopause Society. Menopause, 13, 340–367.
   PubMed Web of Science ®Google Scholar
• Palella, F. J., Jr., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine, 338(13), 853–860.
   PubMed Web of Science ®Google Scholar
• Pan, F., Chernow, M. E., & Fendrick, A. M. (2008). Impact of fixed-dose combination drugs on adherence to prescription medications. Journal of General Internal Medicine, 23(5), 611–614.
   PubMed Web of Science ®Google Scholar
• Panel on Antiretroviral Guidelines for Adults and Adolescents. (2009). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Washington, DC: Department of Health and Human Services. 1–161. Retrieved July 2, 2009, from http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
   Google Scholar
• Patel, P., Hanson, D. L., Sullivan, P. S., Novak, R. M., Moorman, A. C., Tong, T. C., (2008). Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Annals of Internal Medicine, 148(10), 728–736.
   PubMed Web of Science ®Google Scholar
• Pedrazzoni, M., Vescovi, P. P., Maninetti, L., Michelini, M., Zaniboni, G., Pioli, G., (1993). Effects of chronic heroin abuse on bone and mineral metabolism. Acta Endocrinologica, 129(1), 42–45.
   PubMedGoogle Scholar
• Perez, J. L., & Moore, R. D. (2003). Greater effect of highly active antiretroviral therapy on survival in people aged ≥50 years compared with younger people in an urban observational cohort. Clinical Infectious Diseases, 36, 212–218.
   PubMed Web of Science ®Google Scholar
• Phillips, A. N., Carr, A., Neuhaus, J., Visnegarwal, F, Prineas, R., Burman, W. J., (2008). Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: Exploratory analyses from the SMART trial. Antiviral Therapy, 13(2), 177–187.
   PubMed Web of Science ®Google Scholar
• Phillips, A. N., Lee, C. A., Elford, J., Webster, A., Janossy, G., Timms, A., (1991). More rapid progression to AIDS in older HIV-infected people: The role of CD4+ T-cell counts. Journal of Acquired Immune Deficiency Syndromes, 4(10), 970–975.
   PubMed Web of Science ®Google Scholar
• Rabkin, J. G., McElhiney, M. C., Rabkin, R., McGrath, P. J., & Ferrando, S. J. (2006). Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. American Journal of Psychiatry, 163(1), 59–66.
   PubMed Web of Science ®Google Scholar
• Rao, T. K., Filippone, E. J., Nicastri, A. D., Landesman, S. H., Frank, E., Chen, C. K., (1984). Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. New England Journal of Medicine, 310(11), 669–673.
   PubMed Web of Science ®Google Scholar
• Raskind, R. A. (1998). The clinical interface of depression and dementia. Journal of Clinical Psychiatry, 59(Suppl. 10), 9–12.
   PubMedGoogle Scholar
• Riddler, S. A., Smit, E., Cole, S. R., Li, R., Chmiel, J. S., Dobs, A., (2003). Impact of HIV infection and HAART on serum lipids in men. Journal of the American Medical Association, 289(22), 2978–2982.
   PubMed Web of Science ®Google Scholar
• Rietschel, P., Corcoran, C., Stanley, T., Basgoz, N., Klibanski, A., & Grinspoon, S. (2000). Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. Clinical Infectious Diseases, 31, 1240–1244.
   PubMed Web of Science ®Google Scholar
• Rivlin, R. S. (2007). Keeping the young-elderly healthy: Is it too late to improve our health through nutrition? American Journal of Clinical Nutrition, 86, 1176–1181.
   Web of Science ®Google Scholar
• Rothenberg, R., Woelfel, M., Stoneburner, R., Milberg, J., Parker, R., & Truman, B. (1987). Survival with the acquired immunodeficiency syndrome: Experience with 5833 cases in New York City. New England Journal of Medicine, 317, 1297–1302.
   PubMed Web of Science ®Google Scholar
• Sacktor, N., Lyles, R. H., Skolasky, R., Kleeberger, C., Selnes, O. A., Miller, E. N., (2001). HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998. Neurology, 56(2), 257–260.
   PubMed Web of Science ®Google Scholar
• Salazar, J. A., Poon, I., & Nair, M. (2007). Clinical consequences of polypharmacy in elderly: Expect the unexpected, think the unthinkable. Expert Opinion on Drug Safety, 6(6), 695–704.
   PubMed Web of Science ®Google Scholar
• Santoro, N., Lo, Y., Moskaleva, G., Arnsten, J. H., Floris-Moore, M., Howard, A. A., (2007). Factors affecting reproductive hormones in HIV-infected, substance-using middle-aged women. Menopause, 14(5), 859–865.
   PubMed Web of Science ®Google Scholar
• Schoenbaum, E. E., Hartel, D., Lo, Y., Howard, A. A., Floris-Moore, M., Arnsten, J., (2005). HIV infection, drug use, and onset of natural menopause. Clinical Infectious Diseases, 41(10), 1517–1524.
   PubMed Web of Science ®Google Scholar
• Shah, S. S., McGowan, J. P., Smith, C., Blum, S., & Klein, R. S. (2005). Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clinical Infectious Diseases, 35, 1238–1243.
   Web of Science ®Google Scholar
• Sharrett, A. R., Ballantyne, C. M., Coady, S. A., Heiss, G., Sorlie, P. D., Catellier, D., (2001). Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein (a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation, 104(10), 1108–1113.
   PubMed Web of Science ®Google Scholar
• Shuter, J. (2008). Forgiveness of non-adherence to HIV-1 antiretroviral therapy. Journal of Antimicrobial Chemotherapy, 61(4), 769–773.
   PubMed Web of Science ®Google Scholar
• Singh, N., Squier, C., Sivek, C., Wagener, M., Nguyen, M. H., & Yu, V. L. (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Care, 8(3), 261–270.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. (2006). National Survey on Drug Use and Health 2005 and 2006. Rockville, MD: Office of Applied Studies. Retrieved July 8, 2008, from http://www.oas.samhsa.gov/nsduhLatest.htm
   Google Scholar
• Sulkowski, M. S. (2008). Management of hepatic complications in HIV-infected persons. Journal of Infectious Diseases, 197(Suppl. 3), S279–S293.
   PubMed Web of Science ®Google Scholar
• Sulkowski, M. S., & Thomas, D. L. (2003). Hepatitis C in the HIV-infected person. Annals of Internal Medicine, 138, 197–207.
   PubMed Web of Science ®Google Scholar
• Szczech, L. A., Gupta, S. K., Habash, R., Guasch, A., Kalayjian, R., Appel, R., (2004). The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney International, 66(3), 1145–1152.
   PubMed Web of Science ®Google Scholar
• Triant, V. A., Brown, T. T., Lee, H., & Grinspoon, S. K. (2008). Fracture prevalence among HIV-infected versus non HIV-infected patients in a large U.S. healthcare system. Journal of Clinical Endocrinology and Metabolism, 93(9), 3499–3504.
   PubMed Web of Science ®Google Scholar
• Triant, V. A., Hadigan, L. H., & Grinspoon, S. K. (2007). Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. Journal of Clinical Endocrinology and Metabolism, 92(7), 2506–2512.
   PubMed Web of Science ®Google Scholar
• Tumbarello, M., Rabagliati, R., de Gaetano Donati, K., Bertagnolio, S., Montuori, E., Tamburrini, E., (2004). Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy. BMC Infectious Diseases, 4, 46.
   PubMed Web of Science ®Google Scholar
• Tyor, W. R., & Middaugh, L. D. (1999). Do alcohol and cocaine abuse alter the course of HIV-associated dementia complex? Journal of Leukocyte Biology, 65(4), 475–481.
   PubMed Web of Science ®Google Scholar
• United States Renal Data System. (2007). Annual data report 2007: ADR/atlas. Retrieved July 21, 2008, from http://www.usrds.org/adr.htm
   Google Scholar
• Valcour, V., Shikuma, C., Shiramizu, B., Watters, M., Poff, P., Selnes, O., (2004). Higher frequency of dementia in older HIV-1 individuals: The Hawaii aging with HIV-1 cohort. Neurology, 63(5), 822–827.
   PubMed Web of Science ®Google Scholar
• Viard, J. P., Mocroft, A., Chiesi, A., Kirk, O., Roge, B., Panos, G., (2001). Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: Evidence from the EuroSIDA study. Journal of Infectious Diseases, 183(8), 1290–1294.
   PubMed Web of Science ®Google Scholar
• Villette, J. M., Bourin, P., Doinel, C., Mansour, I., Fiet, J., Boudou, P., (1990). Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus. Journal of Clinical Endocrinology and Metabolism, 70(3), 572–577.
   PubMed Web of Science ®Google Scholar
• Walli, R., Herfort, O., Michl, G. M., Demant, T., Jäger, H., Dieterle, C., (1998). Treatment with protease inhibitors associated with peripheral insulin resistance and impaired glucose tolerance in HIV-1-infected patients. AIDS, 12, F167–F173.
   PubMed Web of Science ®Google Scholar
• Wyles, D. L., & Gerber, J. G. (2005). Antiretroviral drug pharmacokinetics in hepatitis with hepatic dysfunction. Clinical Infectious Diseases, 40(1), 174–181.
   PubMed Web of Science ®Google Scholar
• Yun, L. W., Maravi, M., Kobayashi, J. S., Barton, P. L., & Davidson, A. J. (2005). Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 38(4), 432–438.
   PubMed Web of Science ®Google Scholar
• Zhang, L., Looney, D., Taub, D., Chang, S. L., Way, D., Witte, M. H., (1998). Cocaine opens the blood–brain barrier to HIV-1 invasion. Journal of Neurovirology, 4(6), 619–626.
   PubMed Web of Science ®Google Scholar